参考文献/References:
[1] 韩 乐,陈文娟,雷光焰,等.microRNA-21、microRNA-25在肺癌组织中的表达及意义[J].陕西医学杂志,2019,48(12):1596-1600.
[2] 许春伟,吕镗烽,宋 勇.机遇与挑战并存,希望与荣耀同在——不可切除局部晚期/转移性非小细胞肺癌的起始治疗策略[J].循证医学,2020,20(1):6-10.
[3] 才 昊,韩 亮,李晓飞.lncRNA XIST通过调控miR-186-5p促进非小细胞肺癌的增殖和侵袭实验研究[J].陕西医学杂志,2020,49(1):15-21,37.
[4] 卓少华,丘远聪,郑俊德,等.人参皂苷Rg5调控lncRNA-PCAT12抑制胃癌细胞生长实验研究[J].陕西中医,2020,41(4):437-439.
[5] 谭 楠,刘婷婷,赵 昆.长链非编码RNAH19在非小细胞肺癌患者血清中的表达及临床意义[J].陕西医学杂志,2018,47(5):554-556,570.
[6] Wang Y,Chen W,Lian J,et al.The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α[J].Cell Death Differ,2020,27(2):695-710.
[7] Chen S,Wu H,Lv N,et al.LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer[J].Biomed Pharmacother,2016,82:583-588.
[8] Sun Y,Xu J.TCF-4 regulated lncRNA-XIST promotes M2 polarization of macrophages and is associated with lung cancer[J].Onco Targets Ther,2019,2(12):8055-8062.
[9] Zhang X,Guo B,Zhu Y,et al.Up-regulation of plasma lncRNA CACS15 distinguished early-stage oral squamous cell carcinoma patient[J].Oral Dis,2020,26(8):1619-1624.
[10] Gao R,Fang C,Xu J,et al.LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145[J].Arch Biochem Biophys,2019,15(663):183-191.
[11] Zhang C,Wang GX,Fu B,et al.LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p[J].Eur Rev Med Pharmacol Sci,2020,24(13):7215-7228.
[12] Chen J,Hu L,Wang J,et al.Low expression lncRNA TUBA4B is a poor predictor of prognosis and regulates cell proliferation in non-small cell lung cancer[J].Pathol Oncol Res,2017,23(2):265-270.
[13] Jiang C,Yang Y.Long noncoding RNA(LncRNA)HOTAIR affects tumorigenesis and metastasis of non-small cell lung cancer by upregulating miR-613[J].Oncol Res,2018,26(5):725-734.
[14] Fang Z,Chen W,Yuan Z,et al.LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation[J].Biomed Pharmacother,2018,101:536-542.
[15] Wang C,Zi H,Wang Y,et al.LncRNA CASC15 promotes tumour progression through SOX4/Wnt/β-catenin signalling pathway in hepatocellular carcinoma[J].Artif Cells Nanomed Biotechnol,2020,48(1):763-769.
[16] Li C,Zhang Y,Zhao W,et al.MiR-153-3p regulates progression of ovarian carcinoma in vitro and in vivo by targeting MCL1 gene[J].J Cell Biochem,2019,120(11):19147-19158.
[17] Deng X,Guo B,Fan Y.MiR-153-3p suppresses cell proliferation,invasion and glycolysis of thyroid cancer through inhibiting E3F3 expression[J].Onco Targets Ther,2021,18(14):519-529.
[18] Gu C,Cai J,Xu Z,et al.MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling[J].Cell Death Dis,2019,10(10):739-783.
[19] 徐海涛,高宁阳,顾新丰,等.芍药舒筋片通过miRNA-140对骨关节炎大鼠软骨细胞中Wnt/β-catenin信号通路的调控作用[J].陕西中医,2020,41(9):1184-1187.
[20] Liu S,Yang N,Wang L,et al.LncRNA SNHG11 promotes lung cancer cell proliferation and migration via activation of Wnt/β-catenin signaling pathway[J].J Cell Physiol,2020,235(10):7541-7553.